P-55 GASTHER2: Efficacy of adding trastuzumab to standard chemotherapy in patients with advanced HER2-negative gastric cancer and HER2-positive expression in circulating tumor cells

Authors :: Celso Abdon Lopes de Mello
Tiago Felismino
Victor Hugo Fonseca de Jesus
Ludmilla Thomé Domingos Chinen
Aldo Lourenço Abbade Dettino
M. Barros e Silva
Marcos Pedro Guedes Camandaroba
Mauro Daniel Spina Donadio
Newton Augusto Ferreira Rodrigues
V. Souza e Silva
R. Riechelmann
Source :: Annals of Oncology. 31:S107
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Chemotherapy
business.industry
medicine.medical_treatment
HER2 negative
Cancer
Hematology
medicine.disease
Circulating tumor cell
Oncology
Trastuzumab
medicine
Cancer research
In patient
business
medicine.drug

Full Text Access

Tools